Dynavax Technologies | DVAX - EPS Earnings Per Share



Dynavax Technologies reported $0.14 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.13 0.12 Oct/30 2025
FY2025Q2 Jun/2025 0.14 0.10 0.08 Aug/07 2025
FY2025Q1 Mar/2025 -0.77 0.01 -0.07 May/06 2025
FY2024Q4 Dec/2024 0.05 0.04 0.0 Feb/20 2025
FY2024Q3 Sep/2024 0.12 0.12 0.10 Nov/07 2024
FY2024Q2 Jun/2024 0.08 0.06 0.03 Aug/06 2024
FY2024Q1 Mar/2024 -0.07 -0.02 -0.19 May/08 2024
FY2023Q4 Dec/2023 0.0 -0.03 0.45 Feb/22 2024
FY2023Q3 Sep/2023 0.10 -0.04 0.43 Nov/02 2023
FY2023Q2 Jun/2023 0.03 -0.09 0.87 Aug/03 2023
FY2023Q1 Mar/2023 -0.19 -0.13 0.22 May/02 2023
FY2022Q4 Dec/2022 0.45 0.43 0.55 Feb/23 2023


Eps Change Date
AbbVie USD 2.97 0.51 Jun/2025
Adma Biologics USD 0.14 0 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
AstraZeneca USD 2.17 0.32 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Dynavax Technologies USD 0.14 0.91 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
Glaxosmithkline USD 0.35 0.24 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Regeneron Pharmaceuticals USD 12.89 4.67 Jun/2025
Roche Holding CHF 8.57 1.66 Dec/2024
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
TG Therapeutics USD 0.17 0.14 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025